C25H31N5O3S — CID 44716731
N-[(4S,4aS,5S,8aS)-5-hydroxy-4,8a-dimethyl-6-[(2S)-1-[methyl(prop-2-ynyl)amino]-1-oxopropan-2-yl]-4a,5,6,7,8,9-hexahydro-4H-benzo[f][1,3]benzothiazol-2-yl]pyrazine-2-carboxamide (PubChem CID 44716731) has the molecular formula C25H31N5O3S and a molecular weight of 481.62 g/mol. Its IUPAC name is N-[(4S,4aS,5S,8aS)-5-hydroxy-4,8a-dimethyl-6-[(2S)-1-[methyl(prop-2-ynyl)amino]-1-oxopropan-2-yl]-4a,5,6,7,8,9-hexahydro-4H-benzo[f][1,3]benzothiazol-2-yl]pyrazine-2-carboxamide.
| Compound Name | N-[(4S,4aS,5S,8aS)-5-hydroxy-4,8a-dimethyl-6-[(2S)-1-[methyl(prop-2-ynyl)amino]-1-oxopropan-2-yl]-4a,5,6,7,8,9-hexahydro-4H-benzo[f][1,3]benzothiazol-2-yl]pyrazine-2-carboxamide |
|---|---|
| PubChem CID | 44716731 |
| Molecular Formula | C25H31N5O3S |
| Molecular Weight | 481.62 g/mol |
| Exact Mass | 481.21 |
| IUPAC Name | N-[(4S,4aS,5S,8aS)-5-hydroxy-4,8a-dimethyl-6-[(2S)-1-[methyl(prop-2-ynyl)amino]-1-oxopropan-2-yl]-4a,5,6,7,8,9-hexahydro-4H-benzo[f][1,3]benzothiazol-2-yl]pyrazine-2-carboxamide |
| SMILES | C#CCN(C)C(=O)[C@@H](C)C1CC[C@@]2(C)Cc3sc(NC(=O)c4cnccn4)nc3[C@@H](C)[C@@H]2[C@H]1O |
| InChI | InChI=1S/C25H31N5O3S/c1-6-11-30(5)23(33)14(2)16-7-8-25(4)12-18-20(15(3)19(25)21(16)31)28-24(34-18)29-22(32)17-13-26-9-10-27-17/h1,9-10,13-16,19,21,31H,7-8,11-12H2,2-5H3,(H,28,29,32)/t14-,15-,16?,19+,21-,25-/m0/s1 |
| InChIKey | KEBOLAGGVCSDEA-MYTQMEKLSA-N |
| XLogP | 2.97 |
| TPSA | 108.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.62 |
| LogP ≤ 5 | 2.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|